GLP-1 combination therapy signals new benefits in psoriasis
GLP-1 combination therapy may bring added benefits to psoriasis patients, The Hill reports, though no trial design, cohort, or PASI endpoint accompanies the claim.
Topic
Semaglutide
Topic
Semaglutide
GLP-1 Receptor Agonists Linked to Onycholysis in New Study
A new study links GLP-1 receptor agonists to onycholysis — nail-plate detachment — and a broader cluster of nail disorders, addin…
GLP-1 Users Report Onycholysis at Four Times the Rate of Nonusers
An EADV 2026 survey of 1,904 patients found 39% of GLP-1 users reported nail detachment versus 9% of nonusers, with gaps persisti…
GLP-1 Use Linked to Fourfold Higher Rate of Nail Detachment
Nail detachment occurred four times more often in patients on GLP-1 receptor agonists, adding onycholysis to the cutaneous signal…
GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis
A GLP-1 receptor agonist is drawing dermatologic attention as a possible therapy for plaque psoriasis, with MedPage Today surveyi…